Atlas Trials

Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.

Clinical trial NCT01298193 · COMPLETED

Trial details

NCT number
NCT01298193
Sponsor
Spanish Breast Cancer Research Group
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Breast Cancer
Start date
2011-05-01
Primary completion
2013-03-01
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.